: Dr Reddy's Laboratories Limited's profit after tax for the quarter ended September 30 was up 117 per cent to Rs 1092.50 crore against Rs 503.80 crore for the second quarter of FY19, the drug maker said in a filing with bourses on Friday.
Revenue for the quarter under review was up by 26 per cent at Rs 4,801 crore against Rs 3,798 crore in the same quarter last fiscal, it said.
Commenting on the results, Co-Chairman and Managing Director, GV Prasad said "I am pleased with our performance across the businesses and strong cash generation during the quarter. We are progressing well in execution of our strategy and in our transformation journey on quality and efficiency."
Disclaimer: No Business Standard Journalist was involved in creation of this content